MX2013006960A - Composicion inmunogenica estable de antigenos de staphylococcus aureus. - Google Patents

Composicion inmunogenica estable de antigenos de staphylococcus aureus.

Info

Publication number
MX2013006960A
MX2013006960A MX2013006960A MX2013006960A MX2013006960A MX 2013006960 A MX2013006960 A MX 2013006960A MX 2013006960 A MX2013006960 A MX 2013006960A MX 2013006960 A MX2013006960 A MX 2013006960A MX 2013006960 A MX2013006960 A MX 2013006960A
Authority
MX
Mexico
Prior art keywords
staphylococcus aureus
immunogenic compositions
aureus antigens
stable immunogenic
stable
Prior art date
Application number
MX2013006960A
Other languages
English (en)
Other versions
MX350170B (es
Inventor
Sandeep Nema
Lakshmi Khandke
Akihisa Nonoyama
Tamara Shafer Hodge
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of MX2013006960A publication Critical patent/MX2013006960A/es
Publication of MX350170B publication Critical patent/MX350170B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)

Abstract

La presente invención se dirige hacia una composición inmunogénica multi-antígeno o multicomponente liofilizada o reconstituida que comprende al menos un antígeno aislado a partir de una bacteria de estafilococo, y métodos para fabricar la misma.
MX2013006960A 2010-12-22 2011-12-21 Composición inmunogénica estable de antígenos de staphylococcus aureus. MX350170B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061426476P 2010-12-22 2010-12-22
PCT/IB2011/055883 WO2012085872A2 (en) 2010-12-22 2011-12-21 Stable immunogenic compositions of staphylococcus aureus antigens

Publications (2)

Publication Number Publication Date
MX2013006960A true MX2013006960A (es) 2013-07-15
MX350170B MX350170B (es) 2017-08-28

Family

ID=45444677

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013006960A MX350170B (es) 2010-12-22 2011-12-21 Composición inmunogénica estable de antígenos de staphylococcus aureus.

Country Status (19)

Country Link
US (1) US20130259896A1 (es)
EP (2) EP3150222B1 (es)
JP (1) JP6097478B2 (es)
KR (2) KR20130114210A (es)
CN (1) CN103826656B (es)
AU (1) AU2011346535B2 (es)
BR (1) BR112013016153A2 (es)
CA (1) CA2819120C (es)
DK (2) DK2654784T3 (es)
ES (2) ES2769425T3 (es)
HK (1) HK1197370A1 (es)
HU (2) HUE033072T2 (es)
IL (1) IL226793B (es)
MX (1) MX350170B (es)
PL (2) PL2654784T3 (es)
PT (2) PT3150222T (es)
RU (1) RU2570730C2 (es)
SI (2) SI3150222T1 (es)
WO (1) WO2012085872A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2540770T3 (es) 2004-09-22 2015-07-13 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos
SG10201406432RA (en) 2009-06-22 2014-11-27 Wyeth Llc Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
SI2445522T1 (sl) 2009-06-22 2017-10-30 Wyeth Llc Imunogeni sestavki antigenov Staphylococcusa aureusa
AU2011262346B2 (en) * 2010-06-04 2014-12-11 Wyeth Llc Streptococcus pneumoniae vaccine formulations
CN103561762A (zh) * 2011-03-16 2014-02-05 明尼苏达大学董事会 诱导针对葡萄球菌属中细菌的免疫应答的组合物和方法
GB201310008D0 (en) * 2013-06-05 2013-07-17 Glaxosmithkline Biolog Sa Immunogenic composition for use in therapy
CN106163550A (zh) * 2013-12-04 2016-11-23 格林考瓦因有限公司 通过大肠杆菌中合成的糖蛋白疫苗预防金黄色葡萄球菌感染
EP3915579A1 (en) 2013-12-31 2021-12-01 Infectious Disease Research Institute Single vial vaccine formulations
DK3129001T3 (da) * 2014-04-10 2020-01-20 Asit Biotech S A Hsp-fri fremstilling af allergen
US20200360500A1 (en) * 2017-08-16 2020-11-19 Merck Sharp & Dohme Corp. Pneumococcal conjugate vaccine formulations
GB201802339D0 (en) 2018-02-13 2018-03-28 Glaxosmithkline Biologicals Sa Immunogenic composition
KR102649069B1 (ko) 2018-05-31 2024-03-19 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물
KR102058961B1 (ko) * 2018-07-28 2019-12-24 주식회사 엑소코바이오 엑소좀의 동결건조 방법
KR102163806B1 (ko) 2018-07-30 2020-10-07 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
US20230151102A1 (en) * 2020-01-13 2023-05-18 Aptevo Research And Development Llc Methods and compositions for preventing adsorption of therapeutic proteins to drug delivery system components

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4902506A (en) 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4708871A (en) 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
IT1253009B (it) 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6008341A (en) 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
EP0857214A1 (en) 1995-10-16 1998-08-12 Smithkline Beecham Plc Novel saliva binding protein
GB9622159D0 (en) 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
GB9622660D0 (en) 1996-10-31 1997-01-08 Biocine Spa Immunogenic detoxified mutant toxin
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
JP4486748B2 (ja) 1997-11-26 2010-06-23 インヒビテツクス，インコーポレイテツド 黄色ブドウ球菌由来の細胞外マトリックス結合タンパク質
US6680195B1 (en) 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
KR100644953B1 (ko) * 1998-08-31 2006-11-10 인히비텍스, 인코포레이티드 다성분 백신
US6936258B1 (en) 1999-03-19 2005-08-30 Nabi Biopharmaceuticals Staphylococcus antigen and vaccine
US7115730B1 (en) 1999-04-27 2006-10-03 Chiron Srl Immunogenic detoxified mutant E. coli LT-A-toxin
US7384640B1 (en) 1999-09-30 2008-06-10 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant
RU2413520C2 (ru) 2000-06-08 2011-03-10 Интерселл Аг Вакцинная композиция, содержащая иммуностимулирующие олигодезоксинуклеотиды
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
CA2449670A1 (en) 2001-06-07 2002-12-12 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
DE60234695D1 (de) 2001-06-07 2010-01-21 Univ Colorado Mutantenformen von cholera holotoxin als adjuvans
WO2002102829A2 (en) 2001-06-15 2002-12-27 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
NZ561879A (en) 2003-03-07 2009-05-31 Wyeth Corp Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
WO2004083251A2 (en) 2003-03-17 2004-09-30 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
ES2540770T3 (es) 2004-09-22 2015-07-13 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos
EA020459B1 (ru) * 2006-03-30 2014-11-28 Глаксосмитклайн Байолоджикалс С.А. Иммуногенная композиция
AR060187A1 (es) * 2006-03-30 2008-05-28 Glaxosmithkline Biolog Sa Composicion inmunogenica
GB0606416D0 (en) * 2006-03-30 2006-05-10 Glaxosmithkline Biolog Sa Immunogenic composition
US20070253985A1 (en) 2006-04-26 2007-11-01 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
CN106890144A (zh) * 2006-11-07 2017-06-27 赛诺菲巴斯德生物制剂有限责任公司 冻干法稳定疫苗
CA2716399C (en) 2008-03-05 2020-07-21 Pierre Chouvenc Process for stabilizing an adjuvant containing vaccine composition
SI2445522T1 (sl) * 2009-06-22 2017-10-30 Wyeth Llc Imunogeni sestavki antigenov Staphylococcusa aureusa

Also Published As

Publication number Publication date
CA2819120A1 (en) 2012-06-28
EP2654784A2 (en) 2013-10-30
HUE047263T2 (hu) 2020-04-28
AU2011346535A1 (en) 2013-06-13
PL2654784T3 (pl) 2017-08-31
WO2012085872A3 (en) 2012-08-30
RU2013128277A (ru) 2015-01-27
KR101808398B1 (ko) 2017-12-12
RU2570730C2 (ru) 2015-12-10
US20130259896A1 (en) 2013-10-03
EP3150222B1 (en) 2019-11-27
CN103826656B (zh) 2015-08-26
ES2769425T3 (es) 2020-06-25
CA2819120C (en) 2016-07-05
MX350170B (es) 2017-08-28
SI2654784T1 (sl) 2017-01-31
SI3150222T1 (sl) 2020-02-28
JP6097478B2 (ja) 2017-03-15
DK2654784T3 (en) 2017-02-13
BR112013016153A2 (pt) 2017-07-11
AU2011346535B2 (en) 2015-09-24
HUE033072T2 (hu) 2017-11-28
CN103826656A (zh) 2014-05-28
PT2654784T (pt) 2017-02-13
ES2614815T3 (es) 2017-06-02
WO2012085872A2 (en) 2012-06-28
EP2654784B1 (en) 2016-12-07
PL3150222T3 (pl) 2020-05-18
KR20150129071A (ko) 2015-11-18
JP2012136518A (ja) 2012-07-19
IL226793B (en) 2019-02-28
KR20130114210A (ko) 2013-10-16
EP3150222A1 (en) 2017-04-05
DK3150222T3 (da) 2020-01-27
HK1197370A1 (en) 2015-01-16
PT3150222T (pt) 2020-02-03

Similar Documents

Publication Publication Date Title
MX2013006960A (es) Composicion inmunogenica estable de antigenos de staphylococcus aureus.
ZA201903620B (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
AU2018243910A8 (en) A multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
EP3470526A3 (en) Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of use
EP4286000A3 (en) Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
PE20142188A1 (es) Composiciones inmunogenicas de antigenos de staphylococcus aureus
NZ595689A (en) Compositions for immunising against staphylococcus aureus
MX357202B (es) Composicion de particula tipo virus.
PL1954308T3 (pl) Stabilizatory do liofilizowanych szczepionek
AU2013331781A8 (en) Immunogenic composition comprising 1 or more Streptococcus pneumoniae capsular saccharide conjugates and a protein component comprising Protein E and/or PilA from Haemophilus influenzae.
TN2013000378A1 (en) Anti - sclerostin antibody crystals and formulations thereof
MX349948B (es) Proteínas inmunógenas y composiciones para el tratamiento y prevención de streptococcus agalactiae.
TW200716670A (en) Use of panton-valentine leukocidin for treating and preventing staphylococcus infections
MX2015002482A (es) Composicion inmunogenica.
IL276661B1 (en) Immunogenic preparation containing staphylococcal antigens
NZ741342A (en) Daptomycin formulations and uses thereof
ZA201900070B (en) Antibodies with low immunogenicity and uses thereof
JOP20190038B1 (ar) تركيب اقتراني من السكر المتعدد لكبسولة بكتيريا المكورات الرئوية وبروتين حامل واستخداماته
WO2013067160A3 (en) Anti-bacterial polypeptides and pathogen specific synthetic antibodies
WO2012031260A3 (en) Staphylococcus aureus specific human recombinant polyclonal antibodies and uses thereof
GB2568440A (en) Modified factor H binding protein
GB201114923D0 (en) Immunogenic proteins and compositions
MX2020001046A (es) Composicion inmunogenica que comprende un peptido de fusion derivado de toxoides de superantigenos.
NZ626296A (en) Compositions and methods for antibodies targeting factor p
GB2515669A (en) Bacterial vaccine

Legal Events

Date Code Title Description
FG Grant or registration